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The amyloid precursor protein (APP) is the source of Ah fragments implicated in the formation of senile plaques in Alzheimer’s disease (AD).
APP-related proteins are also expressed at high levels in the embryonic nervous system and may serve a variety of developmental functions,
including the regulation of neuronal migration. To investigate this issue, we have cloned an orthologue of APP (msAPPL) from the moth,
Manduca sexta, a preparation that permits in vivo manipulations of an identified set of migratory neurons (EP cells) within the developing enteric
nervous system. Previously, we found that EP cell migration is regulated by the heterotrimeric G protein Goa: when activated by unknown
receptors, Goa induces the onset of Ca2+ spiking in these neurons, which in turn down-regulates neuronal motility. We have now shown that
msAPPL is first expressed by the EP cells shortly before the onset of migration and that this protein undergoes a sequence of trafficking,
processing, and glycosylation events that correspond to discrete phases of neuronal migration and differentiation. We also show that msAPPL
interacts with Goa in the EP cells, suggesting that msAPPL may serve as a novel G-protein-coupled receptor capable of modulating specific
aspects of migration via Goa-dependent signal transduction.
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A hallmark feature of Alzheimer’s disease (AD) is the
accumulation of amyloid plaques in the brain (Glenner and
Wong, 1984; Masters et al., 1985), which are formed
predominantly by short h-amyloid fragments (Ah) that are
derived by proteolytic cleavage of the amyloid precursor
protein (APP; Kang et al., 1987; Suh and Checler, 2002).
APP is a member of a family of transmembrane glycoproteins
with structural similarity to cell surface receptors: they possess
large extracellular domains with several potential protein
interaction motifs, plus short cytoplasmic domains containing
motifs that can interact with a variety of adapter and
intracellular signaling molecules (Annaert and De Strooper,
2002; Turner et al., 2003). At least 10 distinct isoforms of APP
may be generated via alternative mRNA splicing from a single
gene (Sandbrink et al., 1994a,b), but the predominant isoform0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: copenhav@ohsu.edu (P.F. Copenhaver).expressed in the nervous system is APP695 (Kitaguchi et al.,
1988). Proteolytic cleavage of APP by a combination of
juxtamembrane and intramembrane secretases results in the
release of the Ah fragment, which can then aggregate into
amyloid plaques (Selkoe, 1998, 2000). Both the soluble Ah
monomer (Tong et al., 2004; Yankner, 1996) and its aggregates
(Klein, 2002; Selkoe, 2001; Stern et al., 2004) are capable of
inducing a variety of neurotoxic effects, providing support for
the ‘‘amyloid hypothesis’’ that this cleavage product of APP
mediates the neurodegenerative aspects of Alzheimer’s disease
(Hardy and Allsop, 1991; Hardy and Selkoe, 2002; Greeve et
al., 2004).
However, more recent studies on the biological actions of
APP have impelled a modified view of this hypothesis. APP is
expressed at high levels in the developing nervous system and
is localized to regions of neuronal motility and synapse
formation (Akaaboune et al., 2000; Loffler and Huber, 1992;
Masliah et al., 1992). APP has been detected within growth
cones and developing synapses in the mammalian brain
(Akaaboune et al., 2000; Clarris et al., 1995; Kirazov et al.,
2001; Lahiri et al., 2002) and is upregulated in regenerating88 (2005) 160 – 178
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T.L. Swanson et al. / Developmental Biology 288 (2005) 160–178 161olfactory neurons (Struble et al., 1998). In cell culture, APP can
also promote neurite outgrowth (Beher et al., 1996; Qiu et al.,
1995) and cell–substratum adhesion (Chen and Yankner, 1991;
Kibbey et al., 1993). These observations have led to the
proposal that APP is part of a large protein complex normally
involved in the regulation of such processes as neuronal
migration, axonal outgrowth, and synaptic differentiation (Sabo
et al., 2001; Turner et al., 2003), albeit via poorly defined
mechanisms.
More provocative is the co-localization of APP with a
number of molecules in focal complexes at the leading edges of
migratory cells. These include h-integrins (Yamazaki et al.,
1997), which may provide a functional link between APP and
the actin cytoskeleton, and the adapter proteins Fe65, mDAB1,
and members of the X11/Mint family, each of which can bind
to the cytoplasmic domain of APP (Sabo et al., 2001). APP
also directly interacts with the heterotrimeric G protein Goa
(Nishimoto et al., 1993; Giambarella et al., 1997; Okamoto et
al., 1996), a signal transduction molecule that comprises up to
1% of all membrane-associated protein in the developing
nervous system (Edmond et al., 1990) but whose developmen-
tal functions remain poorly understood. Indeed, APP has been
postulated to act as a novel class of G-protein-coupled receptor
(Brouillet et al., 1999; Giambarella et al., 1997), although the
importance of this interaction with respect to the control of
neuronal growth and survival is still controversial (Turner et
al., 2003). Both APP and its proteolytic products are capable of
exerting a variety of actions on cell growth, signal transduction,
and neural plasticity (Kamenetz et al., 2003; Li et al., 1997;
Mucke et al., 1994; Walsh et al., 2002), leading to the proposal
that APP may serve as a ‘‘molecular hub’’ at the center of many
converging regulatory pathways (Turner et al., 2003). Thus,
besides the generation of excessive Ah, aberrant processing of
APP might disrupt one or more of its normal functions in the
brain, which might in turn contribute to the abnormalities
detected in AD. Yet despite a plethora of studies on APP and its
fragments in a variety of assays, the developmental and
physiological roles of APP have remained unclear.
Analysis of the intrinsic functions of APP in vertebrates has
been complicated by the identification of two closely related
proteins (APLP1 and APLP2) which share partially over-
lapping functions with APP (Heber et al., 2000; von Koch et
al., 1997). In contrast, only one APP-related gene is expressed
in Drosophila (appl; Rosen et al., 1989) and Caenorhabditis
(apl-1; Daigle and Li, 1993), which has facilitated investiga-
tions into their normal functions in vivo. The proteins encoded
by these genes share a number of structural similarities with the
vertebrate APP family (Coulson et al., 2000), including the
conserved intracellular domain required for Goa interactions
(Nishimoto et al., 1993; Torroja et al., 1999b). Moreover,
transgenic studies in Drosophila have shown that human
APP695 can rescue at least some of the deficits caused by the
deletion of APPL (Luo et al., 1992), demonstrating that these
proteins are functionally as well as structurally conserved. In
Drosophila, APPL has been implicated in variety of develop-
mental functions, including the acquisition of phototactic
behavior (Luo et al., 1992), axonal transport (Gunawardenaand Goldstein, 2001; Torroja et al., 1999a), and postembryonic
differentiation of neuromuscular synapses (Ashley et al., 2005;
Torroja et al., 1999b). In particular, Torroja et al. found that
selective mutations of the putative Goa-binding domain of
APPL caused specific alterations in the growth of presynaptic
boutons at the neuromuscular junctions (Torroja et al., 1999b),
lending support to the model that APP-related proteins may
functionally interact with Goa in developing neurons.
Surprisingly, genetic deletions of APPL in Drosophila
produced only subtle effects on the developing nervous system
(Li et al., 2004; Luo et al., 1992; Zambrano et al., 2002),
possibly due to compensatory interactions by other functionally
related proteins that may have masked the normal contribution
of APPL to neural development. As an alternative means of
addressing this issue, we have examined the developmental
role of APPL during the formation of the enteric nervous
system (ENS) in the moth Manduca sexta. The ENS in this
species contains a distributed population of neurons (the EP
cells) that occupy a branching nerve plexus (the enteric plexus)
spanning the foregut–midgut boundary (Copenhaver and
Taghert, 1988, 1989b; see Fig. 1). In previous work, we
showed that the EP cells achieve their mature distributions in
the enteric plexus via directed migration along identified sets of
visceral muscles that form on the surface of the gut. After
delaminating from the foregut epithelium, small groups of EP
cells align with one of eight longitudinal muscle bands on the
midgut or with specific radial muscles on the foregut (Fig. 1,
55% of development). Subsequently, the neurons migrate
rapidly along these pathways (between 55 and 65% of
development) before completing their differentiation (Copen-
haver and Taghert, 1989b; Copenhaver et al., 1996). Of note is
that throughout their development, the EP cells grow on the
most superficial layer of the developing gut musculature; thus,
both the neurons and their pathways remain accessible to direct
observations and acute manipulations in embryonic culture
(Horgan et al., 1995; Wright and Copenhaver, 2000).
The guidance of EP cell motility is also precisely
regulated: although they continually extend short filopodial
processes onto the adjacent interband musculature (Fig. 1,
55–60% of development), both the migrating neurons and
their growing axons remain closely apposed to their muscle
band pathways, only branching laterally to innervate the
interband regions towards the end of their differentiation (Fig.
1, 100% of development). In part, the precise guidance of the
EP cells is mediated by fasciclin II (mFas II), a homophilic
adhesion receptor that is expressed by both the neurons and
transiently the muscle bands during the migratory period
(Wright and Copenhaver, 2000, 2001). However, strong
repulsive interactions have also been found to prevent EP
cell migration onto the interband regions (Copenhaver et al.,
1996), a process that may be mediated by the G protein Goa.
All of the neurons commence the expression of Goa just prior
to the onset of migration, and selective activation of Goa
within individual EP cells inhibits their motility in a Ca2+-
dependent manner (Horgan et al., 1994, 1995). However, the
identity of candidate Goa-coupled receptors capable of
inducing this response in the EP cells has remained unknown.
Fig. 1. Formation of the ENS in Manduca involves the stereotyped migration of the EP cells into the enteric plexus. Between 30 and 40% of development (not
shown), the EP cells delaminate from a neurogenic placode to form a coherent packet of pre-migratory neurons on the dorsal foregut surface at the foregut–midgut
boundary (Copenhaver and Taghert, 1990). Then, between 40 and 55% of development, the packet of EP cells (black cells) spreads bilaterally around the foregut–
midgut boundary, and subsets of the neurons (arrows, 55%) gradually align with one of eight longitudinal muscle bands (B) that coalesce from the longitudinal
muscle cells of the midgut (only the dorsal four muscle bands are shown). As midgut closure is completed (between 55 and 60% of development), the EP cells
commence a rapid phase of migration onto the longitudinal muscle bands of the midgut and onto specific radial muscles on the foregut (radial muscles are not
shown). During this period of active migration, each of the EP cells extends filopodial processes in advance of their cell body onto both their muscle band pathways
and onto the adjacent interband regions (IB). However, both the migration (from 55 to 65% development) and subsequent outgrowth of these neurons (from 65 to
75% development) are restricted to the muscle bands, while they avoid the interband regions. Although the EP cells tend to migrate in small groups, each neuron
moves independently, traveling over both the underlying muscle band cells and adjacent neurons in an apparently stochastic manner. By the completion of
embryogenesis (100% of development), this migratory sequence has resulted in eight dispersed columns of neurons that are distributed along the anterior segments of
each muscle band. Only after their migration and outgrowth are complete do the EP cells branch laterally onto the interband regions, providing a diffuse innervation
of the lateral musculature (Copenhaver and Taghert, 1989a). Although the timing of migration and the pathways followed by the EP cells are highly stereotyped, their
final positions along a muscle band are not; rather, these neurons subsequently express one of several distinct neuronal phenotypes that are regulated in part by their
final location (Copenhaver et al., 1996). Because the EP cells and their muscle band pathways occupy the most superficial layer of the gut, these neurons remain
accessible to direct observation and experimental manipulations throughout embryogenesis. Percentages indicate percent of development (1% development = 1 h of
real time at 25-C). B = midgut muscle band; IB = interband regions; fg/mg = foregut–midgut boundary. Scale = 30 Am.
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encoding APPL in Manduca (designated msAPPL), and we have
analyzed its developmental expression and processing in the EP
cells with respect to their migration and differentiation. We have
also investigated whether msAPPL and Goa interact within the EP
cells during their migration. The results of these studies suggest a
novel role for APP-related proteins in the control of neuronal
motility within the developing nervous system.
Materials and methods
Developmentally synchronized embryos were collected from a colony ofM.
sexta andmaintained at 25-C; at this temperature, embryogenesis is completed in
100 h (1% development = 1 h). Developmental staging, immunoblots, and
whole-mount immunohistochemistry were performed as previously described
(Horgan and Copenhaver, 1998;Wright et al., 1998). Antibodies were used at the
following concentrations: anti-mFas II: 1:20,000 (Wright et al., 1999); anti-
ELAV 1:500 (Robinow and White, 1991; gift from Dr. Kalpana White); anti-
Drosophila APPL: 1:1000 (dAPPL; gift from Drs. Kalpana White and Vivian
Budnik); and affinity-purified anti-Goa: 1:100 (Horgan et al., 1995). We also
generated two antibodies against msAPPL: anti-msAPPL-cyt against the C-
terminal (CZ)YENPTYKYFEVKE sequence (used at 1:5000); and anti-
msAPPL-ect against the extracellular domain (CZ)EDDDYTDADD-
SAWPRPES sequence (used at 1:1000). For whole-mount immunostaining,
primary antibodies were detected using the HRP-based ABC protocol of Vectorlaboratories (Burlingame, CA) or using fluorochrome-conjugated secondary
antibodies (Cy3-conjugates from Jackson Labs, West Grove, PA; and Alexa-488
and -568 conjugates from Molecular Probes, Eugene, OR). Whole-mount
immunostained preparations were then photographed by conventional micros-
copy or imaged by confocal microscopy, either with an Olympus Fluoview 300
laser scanning confocal head mounted on an Olympus BX51 microscope or with
a BioRad 1024 ES laser scanning confocal microscope.
Primary neuronal cultures were prepared after the methods of Hayashi et al.
(Hayashi and Hildebrand, 1990; Hayashi and Levine, 1992). Briefly,
desheathed ganglia were harvested from P0–P1 stage Manduca pupae,
enzymatically dissociated with trituration, and plated onto glass coverslips
coated with Concanavalin A plus Laminin (4–5 ganglia per dish). After 4 days
in L-15-based culture medium (Gibco; Carlsbad, CA) plus 10% fetal bovine
serum (FBS), the neurons were rinsed and grown for 2 additional days in
reduced protein L-15 medium (L-15 plus 1 Ag/ml 20-hydroxyecdysone, 100 U/
ml penicillin, 100 U/ml streptomycin; from Sigma; St. Louis, MO). The
medium from the cultures was then harvested and concentrated to a final
volume of 30 Al (using a 30 kDa cut-off Centricon spin concentrator; Amicon;
Beverly, CA), while the neurons were harvested in RIPA buffer (150 mM NaCl,
1% IGEPAL, 0.5% deoxychoic acid, 1% SDS, 50 mM Tris pH 8.0) for
immunoblot analysis.
For immunoblots, soluble protein was extracted from pooled tissue samples
collected from synchronous groups of embryos in lysis buffer or from primary
neuronal cultures as described above. The protein samples were then separated
by polyacrylamide gel electrophoresis (after our published methods; Wright
and Copenhaver, 2000) and transferred to nitrocellulose. Replicate blots were
incubated either with the primary antibodies listed above, with pre-immune
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against the synthetic peptides used as their antigens (in a 10:1 molar ratio).
Aliquots of each anti-msAPPL antibody were also cross pre-adsorbed with the
peptide epitope used to generate the other antibody as an additional control for
the specificity of our adsorption protocol. Bound antibodies were then detected
either with alkaline-phosphatase-conjugated secondary antibodies (1:2500;
KPL; Gaithersburg, MD), detected by a colorimetric reaction or with HRP-
conjugated secondary antibodies (anti-chicken at 1:10K from Promega,
Madison, WI; other HRP-conjugated secondary antibodies at 1:10 K from
Jackson Immunoresearch, West Grove, PA), and detected by chemilumines-
cence using the Supersignal WestPico kit from Pierce (Rockford, IL) or the
enhanced Visualizer kit from Upstate (Lake Placid, NY).
A partial clone of Manduca APPL (msAPPL) was obtained from
embryonic cDNA, using degenerate PCR primers against evolutionarily
conserved domains of APP-related proteins from other species (Daigle and
Li, 1993; Rosen et al., 1989; Wasco et al., 1992, 1993). 32P-labeled probes
derived from this clone were then used to isolate clones from a cDNA library
(gift of Dr. James Nardi) that contained the full-length coding sequence for
msAPPL. Nucleotide sequencing was performed on an ABI 377 automated
fluorescence sequencer and analyzed using the DNASTAR suite of programs.
For Northern blots, 32P-labeled probes were prepared from a cDNA clone
containing the 1.6 kb open reading frame of msAPPL and used to label blots of
poly A+ mRNA that had been isolated from embryos with the MicroPoly(A)-
Purist kit from Ambion. The mRNA was separated on a 1% agarose gel,
transferred to a nylon membrane, hybridized with probe overnight at 80-C, and
exposed to film after extensive washing. Whole-mount in situ hybridization
histochemical staining of staged embryos was performed following published
methods (Wright et al., 1999; Patel and Goodman, 1992), using digoxigenin-
labeled probes generated against the 1.6 kb cDNA clone encoding msAPPL.
Bound probe was detected in filleted embryos using an alkaline-phosphatase-
conjugated anti-digoxigenin antibody (1:2000; Roche).
For co-immunoprecipitation of APPL and Goa, tissues were collected from
developmentally synchronous groups of embryos or from desheathed pupal
ganglia and frozen on dry ice. The samples were then homogenized in RIPA
buffer for 20 min at room temperature, spun briefly, and the supernatant pre-
cleared with Gammabind Plus Sepharose beads (25 Al in 250 Al; from
Pharmacia). Replicate samples were then incubated either with 1–10 Al of each
anti-msAPPL antibody, pre-immune sera, or with aliquots of the anti-msAPPL
antibodies that had been pre-adsorbed against their synthetic peptides, as
described above. Antibodies were added to the tissue homogenates for 3–4 h at
room temperature followed by the addition of 25 Al washed beads (pre-
adsorbed with 1% IgG-free bovine serum albumin) for 1 h at room temperature.
Beads with bound antibody were then pelleted by centrifugation, washed three
times in chilled RIPA buffer, and then resuspended in SDS sample buffer
(Wright et al., 1999). After boiling for 5 min, the total volume of the
resuspended pellets or 30 Al aliquots of the residual supernatants from each
immunoprecipitation reaction were separated on 12% SDS polyacrylamide
gels, transferred to nitrocellulose, and immunoblotted with anti-Goa antibodies.
Labeled bands were visualized using HRP-conjugated secondary antibodies
detected with the Visualizer kit (Upstate).
For removal of N-linked glycoproteins from msAPPL, staged groups of
embryos (at 65% of development) were homogenized in RIPA buffer plus
protease inhibitors at room temperature for 15 min. Alternatively, the tissue
samples were homogenized in hot extraction buffer (10% glycerol; 1% mM
SDS, 50 mM Tris pH 6.7) plus inhibitors for 5 min at 100-C. The samples were
cleared by brief (5 min) microcentrifugation, and the soluble fractions
incubated with the deglycosylating enzyme PNGase F (Peptide: N-Glycosidase
F; 500 U/Al; New England Biolabs; Beverly, MA) following the manufacturer’s
instructions for 16–24 h at 37-C. Control samples were treated in an identical
manner but without the addition of PNGase. Replicate samples were also
reacted with a1–2 Fucosidase (10 U/Al; New England Biolabs) or O-glycanase
(1.25 mU/Al; Prozyme, San Leandro, CA) as per the manufacturers’ suggested
protocols. The resultant protein samples were then separated on polyacrylamide
gels, transferred onto nitrocellulose, and immunoblotted with our antibodies
against either the cytoplasmic domain (anti-msAPPL-cyt) or extracellular
domain (anti-msAPPL-ect) of msAPPL or with antibodies that had been pre-
adsorbed against their peptide epitopes. Immunoblots that had been reacted
with one antibody were routinely stripped and re-probed with the otherantibody for an exact comparison of the protein bands recognized by antibodies
specific for the different domains of msAPPL.
Results
The gene encoding msAPPL is developmentally expressed in
the migratory EP cells
As an initial means of examining whether APPL-related
proteins are expressed by the EP cells during their migration,
we used an antiserum against Drosophila APPL (dAPPL) to
immunostain embryos at 58% of development, a stage when
the EP cells are still migrating but have also begun to extend
axonal processes (see Fig. 1). Strong immunostaining was
detected in all of the EP cells as they migrated onto the midgut
muscle bands (Fig. 2A, arrows), including robust staining
within their leading processes (Fig. 2A, arrowheads). To verify
that these neurons express authentic APPL, we isolated a
cDNA clone encoding the Manduca homologue of APPL
(designated msAPPL; nucleotide and deduced amino acid
sequences are shown in Supplemental Fig. 1). This cDNA
clone contained a single open reading frame encoding a 732
AA protein that shares 51% overall sequence identity with
dAPPL and 33% overall identity with human APP695. The
predicted structure of msAPPL is closely similar to other
members of the APP family: it is a type-one transmembrane
protein with several potential sites for N-linked glycosylation
(see annotations in Supplemental Fig. 1). It also has the
characteristic extracellular domains (E1 and E2) and cytoplas-
mic domain (C) found in all APP-related proteins (Bush et al.,
1994; Coulson et al., 2000), although like dAPPL in
Drosophila and APL-1 in C. elegans, msAPPL does not share
sequence conservation with the Ah region of human APP
(Supplemental Fig. 2). msAPPL also lacks the large inserted
sequences found between the E1 and E2 domains of
Drosophila (Supplemental Fig. 2), so that the predicted
molecular weight of its core protein (81 kDa) is closer to that
of APP695.
Sequence conservation between msAPPL and other APP-
related proteins was found to be especially strong within its
extracellular (E1 & E2) and cytoplasmic (C) domains (Fig.
2B). The E1 domain of msAPPL is 66% identical to that of
dAPPL and 43% identical with human APP695, while the E2
domain is 60% identical with that of dAPPL and 36% identical
with APP695. Of particular note is the high degree of sequence
similarity between the cytoplasmic (C) domains of msAPPL
and the equivalent domains in both fly (88%) and human
APP695 (77%), including a 100% conserved TPEERH se-
quence within the Goa binding domain of APP695 (Nishimoto
et al., 1993) and a 100% conserved NGYENPTYK sequence
within the internalization motif required for interactions
between APP695 and the adapter proteins FE65, X11/Mint,
and DAB1 (Turner et al., 2003).
To examine the expression pattern of msAPPL-specific
mRNA, 32P-labeled riboprobes were generated from our
msAPPL cDNA clone and used in Northern blots of poly
A+ mRNA isolated from developing embryos. As shown in
Fig. 2. The migratory EP cells express msAPPL, a member of the APP family. (A) Whole-mount preparation of a 58% embryo dissected to expose the migrating EP
cells and immunostained with an antibody against dAPPL. Immunoreactivity can be clearly seen throughout the neuronal cell bodies (arrows) and in their leading
processes (arrowheads) that are growing on the midgut muscle band pathways. Scale = 10 Am. (B) Amino acid alignment of conserved domains in msAPPL
compared with Drosophila APPL (dAPPL), human APP695 (hAPP), mouse APP (mAPP), and C. elegans APL. Identical residues are shaded in black, similar
residues are shaded in gray. Extracellular domains E1 and E2 represent putative protein interaction domains in the N-terminal regions of this protein family (see
Supplemental Fig. 2 for schematic comparison of these structures). The C-terminal cytoplasmic domain contains the conserved putative binding site for Goa and an
‘‘internalization’’ motif (Int) that contains the binding sites for Fe65, X11/Mint, and DAB1 in vertebrate APPs. GenBank accession numbers for the sequences used in
this alignment are #1303338A for human APP695; #AAH70409 for mouse APP; #AAA28874 for Drosophila APPL; and #AAA98722 for C. elegans APL-1.
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¨6.0 kb, similar to the 6.5 kb transcript reported for dAPPL
mRNA (predicted to encode the slightly larger dAPPL
protein; Rosen et al., 1989). Digoxigenin-labeled riboprobes
were then used for in situ hybridization histochemical
staining of staged embryos throughout the periods of EP
cell neurogenesis, migration, and differentiation (Fig. 4). We
previously showed that the EP cells first emerge from a
neurogenic placode in the posterior dorsal lip of the foregut
epithelium, a process that occurs between 30 and 40% of
development (Copenhaver and Taghert, 1990). As shown in
Fig. 4 (at 35% of development), no detectable msAPPL-
specific mRNA was apparent in the EP cells during their
initial delamination (arrows). In contrast, strong expression
levels were apparent at this stage in neurons within the
frontal ganglion on the anterior foregut (FrGl; arrowhead),
which are born at an earlier period of development
(Copenhaver and Taghert, 1991). By 40% of development,
a stage when the EP cells are post-mitotic but have not yet
begun to migrate (Copenhaver and Taghert, 1989b), faint
levels of msAPPL mRNA could first be detected within the
clustered neurons (Fig. 4, 40%). Staining intensities in the
EP cells then steadily increased over the next 15% of
development (40–55%), when the neurons spread circum-
ferentially around the foregut–midgut boundary (black hatch
marks in Fig. 4; see also Fig. 1 for orientation). All of the
neurons continued to express robust levels of msAPPL-
specific mRNA during their subsequent phase of fast
migration onto the midgut muscle bands (Fig. 4, 55–65%
of development; arrows indicate the progression of EP cell
migration onto the mid-dorsal muscle bands). This patternpersisted throughout their subsequent periods of axon
outgrowth (65–85%) and target innervation (75–100%;
Copenhaver and Taghert, 1989a,b).
Elsewhere in the enteric nervous system, the expression
levels of msAPPL mRNA remained high in all post-mitotic
neurons that had migrated anteriorly along the course of the
esophageal nerve (EN) to form the frontal ganglion (FrGl) and
hypocerebral ganglion (HcGl) of the foregut (Fig. 5A).
Throughout embryogenesis, strong msAPPL-specific staining
was also detectable in neurons within the ganglia of the central
nervous system (Fig. 5B) and in clusters of peripheral neurons
on the body wall (Fig. 5B, arrowheads). In contrast, no
detectable staining was seen in either central or peripheral glial
cells nor in any other non-neural cell type within the embryo.
These results indicate that msAPPL is a neuron-specific protein
whose expression commences only after cells have completed
their terminal mitosis. In the ENS, msAPPL expression in the
EP cells coincides with the onset of their migratory behavior
and persists throughout their subsequent phases of outgrowth
and synapse formation.
msAPPL expression and processing are developmentally
regulated in the ENS
In Drosophila, dAPPL has been shown to be expressed
predominantly as a single glycosylated protein species of ¨145
kDa, from which a ¨130 kDa secreted fragment is rapidly
processed by one or more secretase-like proteases (Luo et al.,
1990). Immunoblots of protein extracted from the postem-
bryonic CNS (Fig. 3B, lane 1) revealed a larger immunoreac-
tive species at ¨135 kDa and a smaller species at ¨120 kDa. A
Fig. 3. Pattern of msAPPL-associated isoforms in the embryonic nervous
system at the time of hatching (100% of development). (A) Northern blot of
embryonic poly A+ mRNA with a 32P-labeled riboprobe specific for msAPPL
revealed one prominent band at ¨6.0 kb. (B) Immunoblot of protein extracts
reacted with an antiserum against dAPPL, which recognizes a conserved motif
in the ectodomain of msAPPL. Lane 1 = extract of Manduca larval CNS; lane
2 = extract from embryos at 100% of development; lane 3 = extract of
Drosophila CNS. Arrows in panel B indicate the apparent size of full-length
msAPPL (¨135 kDa) and the secreted ectodomain (¨120 kDa). (C) Neurons
in primary culture express both the 135 and 120 kDa bands but secrete only the
120 kDa band into the surrounding culture medium. Immunoblot in panel C
was labeled with our anti-msAPPL-ect antibody (against a peptide within the
extracellular domain of msAPPL; see Supplemental Fig. 3). Lane 1 = extract of
intact CNS; lane 2 = extract of primary neurons (isolated from pupal ganglia)
after 6 days in culture; lane 3 = protein collected from the surrounding culture
medium (harvested at the same time as the neurons); only the 120 kDa band
was detected in the culture medium. (D) Identical immunoblot as shown in
panel C that was labeled with an aliquot of the anti-msAPPL-ect antibody that
had been pre-adsorbed against its specific peptide epitope. (E) Identical
immunoblot as shown in panel C that was labeled with the anti-msAPPL-cyt
antibody (against a peptide within the cytoplasmic domain of msAPPL; see
Supplemental Fig. 3). This antibody detected the 135 kDa band but not the 120
kDa band in both CNS extracts (lane 1) and extracts from primary neurons
(lane 2); no protein bands were labeled by this antibody in the medium sample
(lane 3). The anti-msAPPL-cyt antibody also labels several larger bands in
embryonic extracts that may represent isoforms of msAPPL with additional
post-translational modifications (see Fig. 6); one of these bands is faintly
detectable in lane 1 (above the 135 kDa band). A smaller band at ¨117 kDa
(arrowhead) detected by this antibody may represent a degradation product or
an immature form of msAPPL. (F) Identical immunoblot as shown in panel E
that was labeled with an aliquot of the anti-msAPPL-cyt antibody that had been
pre-adsorbed against its specific peptide epitope. These results support the
conclusion that the 135 kDa band represents the holoprotein (detected by both
N- and C-terminal-specific msAPPL antibodies), while the 120 kDa band
represents the secreted ectodomain (detected by the N-terminal but not the C-
terminal-specific antibody) that is released from the surface of growing
neurons.
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2), although the 120 kDa band was substantially more
abundant than 135 kDa band. As described below, this smaller
120 kDa band most likely represents the soluble ectodomain of
msAPPL that is released after cleavage of the holoprotein by
secretase activity, similar to the pattern seen in Drosophila. Theapparent sizes of these proteins inManduca are slightly smaller
than those seen in Drosophila extracts (Fig. 3B, lane 3), as
expected from the predicted amino acid sequences of the moth
versus fly proteins (80 AA versus 98 AA; Luo et al., 1990) (see
also Supplemental Fig. 2).
To examine whether the smaller 120 kDa band does
represent the secreted ectodomain of msAPPL, we generated
anti-peptide antibodies against specific sequences within the N-
and C-terminal domains of the predicted protein (designated
anti-msAPPL-ect and anti-msAPPL-cyt, respectively). The
anti-msAPPL-ect antibody would be predicted to recognize
both the holoprotein and any ectodomain fragments released by
juxtamembrane secretase activity, while the anti-msAPPL-cyt
antibody should recognize the holoprotein but not secreted
ectodomains (see Supplemental Fig. 3). We then used primary
cultures of Manduca CNS neurons to test whether the 120 kDa
band was selectively released from the neurons into the
surrounding medium. As shown in Fig. 3C, the anti-
msAPPL-ect antibody recognized both the 135 kDa and 120
kDa bands in extracts prepared from intact CNS (lane 1) and in
extracts of the primary neurons (lane 2; harvested 6 days after
plating), but only the smaller 120 kDa band was detected in the
surrounding medium (Fig. 3C, lane 3). All immunostaining
was eliminated when we pre-adsorbed the antibody with the N-
terminal domain peptide against which it was generated (Fig.
3D), whereas pre-adsorption of this antibody with the peptide
used to generate the msAPPL-cyt antibody had no such effect
(not shown).
In contrast, the anti-msAPPL-cyt antibody recognized only
the larger 135 kDa band but not the 120 kDa band in extracts of
both CNS (Fig. 3E, lane 1) and primary neurons (lane 2). This
antibody also labeled several larger isoforms (discussed below)
and a band at ¨117 kDa (Fig. 3E, arrowhead), which may be
an immature form of msAPPL or a degradation product.
However, none of these bands were detected in the surrounding
medium (Fig. 3E, lane 3). As with the N-terminal-specific
antibody, pre-absorption of the anti-msAPPL-cyt antibody with
its peptide epitope eliminated all detectable staining (Fig. 3F),
whereas pre-adsorption with the peptide used to generate the
anti-msAPPL-ect antibody had no effect (not shown). These
results support the conclusion that the 120 kDa band detected
with either the anti-dAPPL or anti-msAPPL-ect antibodies
(both of which recognize epitopes in the extracellular regions
of msAPPL) represents the secreted ectodomain of msAPPL,
consistent with the release of the extracellular portions of other
APP family proteins by juxtamembrane secretases (De
Strooper and Annaert, 2000; Luo et al., 1990).
To examine the developmental expression of msAPPL over
the course of embryonic development, we isolated body wall
tissues (containing the CNS and PNS) and midgut tissue
(containing the ENS) from embryos starting at 40% of
embryogenesis, at which stage the EP cells have just begun
to express the msAPPL gene. Equal amounts of total protein
were then examined in immunoblots stained with antisera
recognizing the N-terminal domain of msAPPL. In extracts of
the body wall (Fig. 6A; containing protein from the CNS and
PNS), msAPPL-related protein could be detected at 40% of
Fig. 4. Developmental expression of msAPPL mRNA in the EP cells. Whole-mount in situ hybridization histochemical staining of the ENS in embryos at
progressive stages of development labeled with digoxigenin-labeled riboprobes against msAPPL mRNA. At 35%, the EP cells are still delaminating from a
neurogenic placode (arrows) in the dorsal foregut lip and do not express detectable msAPPL mRNA; in contrast, neurons in the more anterior frontal ganglion (FrGl;
born in an earlier wave of neurogenesis) express strong levels of msAPPL mRNA at this stage. By 40% of development, the EP cells form a coherent packet of post-
mitotic neurons (arrows) on the dorsal foregut surface and express faint levels of msAPPL mRNA. Between 45 and 53%, the EP cells spread bilaterally around the
foregut–midgut boundary and acquire strong expression levels of msAPPL mRNA. Between 53 and 55% of development, subsets of the EP cells align with the
developing midgut muscle bands (arrows indicate positions of mid-dorsal muscle bands; compare with Fig. 1). Subsequently (from 55 to 65%), the neurons migrate
posteriorly along the eight muscle bands onto the midgut. Arrows indicate progression of EP migration onto the mid-dorsal pair of band pathways (the dorsal four
band pathways are visible in the 65% panel; compare with Fig. 1). High levels of msAPPL mRNA persist in the EP cells throughout their subsequent periods of
axonal outgrowth (75–85%) and terminal differentiation (85–100% of development). Percentages indicate developmental stage of the embryos (in % of total
embryogenesis). FrGl = frontal ganglion on the anterior foregut; black hatchmarks indicated the foregut–midgut boundary (fg/mg); scale bar = 30 Am.
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dendritic outgrowth by both central and peripheral neurons.
Initially, both the 135 kDa and 120 kDa bands were of equal
intensity, but, as development progressed, the 120 kDa band
became markedly more intense (Fig. 6A, 65–85%). Given our
data suggesting that the 120 kDa band represents the secreted
ectodomain of msAPPL (Fig. 3), these results indicate that
most of the protein expressed in the CNS was rapidlyprocessed by one or more secretases during this period.
However, by the completion of embryogenesis (100%), the
relative abundance of the two isoforms had returned to
approximately equal levels (as also shown in Fig. 3B, lane 1).
A similar trend was also detected in extracts containing
proteins from the ENS (Fig. 6B). At 40% of development, soon
after the onset of msAPPL expression by the EP cells (see Fig.
4), both the 135 kDa and 120 kDa isoforms could be detected
Fig. 6. Immunoblot analysis of the developmental expression and processing of
msAPPL in the CNS and ENS. (A) Extracts of the embryonic body wall
(containing the embryonic CNS and peripheral neurons); (B) extracts of the
foregut –midgut region (containing the developing EP cells and their
processes). Paired arrows to the left of the blots indicate the position of full-
length msAPPL (135 kDa) and the secreted ectodomain (120 kDa). Black
arrowheads indicate the higher molecular weight isoforms (155–180 kDa) that
are present in the EP cells during their phases of migration and outgrowth (40–
85% of development; also faintly seen at 85% in panel A). (C) Treatment of
msAPPL in embryonic lysates with the deglycosylating enzyme PNGase F.
Blots were labeled with a combination of our anti-msAPPL-cyt and anti-
msAPPL-ect antibodies to reveal all detectable isoforms of msAPPL. Lane 1 =
control sample of embryonic lysate prepared in RIPA buffer; arrows indicate
the 135 and 120 kDa bands, arrowheads indicate the 155–180 trio of higher
molecular weight bands. Lane 2 = embryonic lysate incubated overnight in
PNGase buffer but without PNGase; no artifactual degradation of the msAPPL-
associated bands was detected. Lane 3 = identical sample reacted overnight in
PNGase buffer plus PNGase; the large trio of bands (155–180 kDa) was
reduced in apparent size by ¨10–12 kDa, while the 135 and 120 kDa bands
were reduced by 3–4 kDa. Lane 4: embryo lysate prepared in hot extraction
buffer (see Materials and methods) and incubated overnight in PNGase buffer
without PNGase. Lane 5: identical sample as in Lane 4 reacted with PNGase;
the trio of higher molecular weight bands (arrowheads) was eliminated by this
treatment, while the 135 kDa band was enhanced in intensity. However, the 135
and 120 kDa bands exhibited only minimal changes in their apparent size. Lane
6: an identical sample of embryonic lysate as shown in lane 1 that was labeled
with anti-msAPPL antibodies that had been pre-adsorbed against their peptide
epitopes; all detectable immunolabeled bands were eliminated by the pre-
adsorption protocol.
Fig. 5. Developmental expression of msAPPL mRNA in the ganglia of the ENS
and CNS precedes that of the EP cells. (A) Whole-mount in situ hybridization
histochemical staining of the foregut portion of the ENS shows strong levels of
msAPPL gene expression in the neurons that migrate anteriorly to form the
frontal ganglion (FrGl; arrow) and hypocerebral ganglion (HcGl; arrowhead;
compare with Fig. 3, 35% of development). msAPPL-positive neurons continue
to migrate into the hypocerebral ganglion via the developing esophageal nerve
(EN) throughout the first half of embryogenesis. (B) Expression of msAPPL
mRNA is also clearly detectable at 35% of development in neurons within the
ganglia of the CNS and in the peripheral neurons of the body wall
(arrowheads); expression levels remain high in the CNS throughout the
remainder of embryonic development. FrGl = frontal ganglion; HcGl =
hypocerebral ganglion; EN = esophageal nerve of the foregut. Scale bar = 15
Am in panel B, 35%, and 40 Am in all other panels.
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also detected three larger bands with apparent molecular
weights of 155–180 kDa (Fig. 6B, arrowheads) that were not
seen in postembryonic tissue extracts. These larger protein
species remained abundant throughout subsequent phases of
EP cell migration (55–65%) and outgrowth (70–85%), while
the 135 kDa band was reduced in relative intensity throughout
much of this period. Only towards the end of embryogenesis
did the 135 kDa band become more apparent. By 100% of
development (hatching), the higher molecular weight bands
were no longer detectable, leaving only the 135 kDa and 120
kDa bands (as seen in the CNS).
Previous studies have shown that both human APP695 and
fly dAPPL isoforms are often glycosylated (Weidemann et al.,
1989; Luo et al., 1990), and, as noted above, the predicted
sequence for msAPPL includes at least three potential sites for
N-linked glycosylation, as well as potential sites for O-
glycosylation and fucosylation (Supplemental Fig. 1). To test
whether the larger protein species seen in Fig. 6B (arrowheads)
might represent hyperglycosylated isoforms of msAPPL, we
reacted embryonic lysates with PNGase F to remove N-linked
glycoproteins (Plummer and Tarentino, 1991) and then
examined them in immunoblots labeled with a combination
of our anti-msAPPL antibodies to reveal all potential isoforms.
When we used embryo extracts prepared in RIPA buffer, we
found that both the 135 kDa and 120 kDa bands (putatively thefull-length and secreted ectodomains of msAPPL) were shifted
to lower apparent molecular sizes by 3–4 kDa (compare lanes
2 and 3 in Fig. 6C), consistent with the effects of perturbing
endoglycosylation in other APP family proteins (Luo et al.,
1990; Oltersdorf et al., 1990). A larger shift was seen in the
apparent sizes of the higher molecular weight bands, each
being reduced by ¨10–12 kDa. When we prepared embryonic
lysates with hot extraction buffer (as per the manufacturer’s
suggestion), we also observed the 155–180 kDa trio of bands
plus the 135 and 120 kDa isoforms (Fig. 6C, lane 4). However,
treatment of this preparation with PNGase completely elimi-
nated the higher molecular weight bands, while the intensity of
the 135 kDa band was enhanced (Fig. 6C, lane 5), suggesting
that the higher molecular weight isoforms might represent
hyperglycosylated forms of full-length msAPPL. In contrast,
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120 kDa bands with this treatment. Pre-incubation of the
antisera with their peptide epitopes eliminated labeling of the
trio of higher molecular weight proteins as well as the 135 and
120 kDa isoforms, (Fig. 6C, lane 6; compare with lane 1).
Because the residual size of the deglycosylated bands in
either of these reaction conditions was still substantially larger
than the predicted mass of the core protein of msAPPL (¨81
kDa), we also reacted embryo extracts with O-glycanase (to
remove O-linked glycoproteins) or a1–2 Fucosidase (to
remove fucosyl side groups); however, neither of these
treatments further reduced the apparent size of the msAPPL
isoforms (not shown). Additional modifications that may
contribute to this discrepancy in size are discussed below.
Nevertheless, these results indicate that msAPPL undergoes a
dynamic sequence of post-translational modification andFig. 7. Expression of msAPPL protein in the EP cells during their slow spreading p
(40, 45, and 55% of development) were immunostained as whole-mount preparation
row), or ELAV (bottom row). Arrows at 40% indicate the initial position of the E
migration; arrowheads indicate the anterior cluster of associated glial precursors that
EP cell clusters that have begun to align with the mid-dorsal pair of muscle bands (
(fg/mg); EN = esophageal nerve of the foregut. Scale bar = 30 Am.processing in the EP cells over the course of their migration
and subsequent differentiation.
Developmental trafficking of msAPPL during EP cell
differentiation
To gain a better understanding of how msAPPL is
distributed in the EP cells during their migration, we
immunostained identically staged embryos either with anti-
bodies against the cell adhesion receptor fasciclin II (mFas II;
to show the full extent of EP cell outgrowth; Wright et al.,
1999) or with our anti-APPL antibodies. A third set of matched
preparations was stained with an antibody against ELAV
(Robinow and White, 1991), an unambiguous neuronal marker
that we have shown labels the EP cells but not enteric glial cells
(Copenhaver, 1993). As previously described (Copenhaver andhase of development (40–55% of embryogenesis). Identically staged embryos
s either with antibodies against Manduca fasciclin II (top row), APPL (middle
P cell packet on the foregut before the onset of the lateral spreading phase of
do not express msAPPL or ELAV. Arrows at 55% of development indicate the
compare with Fig. 4). Black hatchmarks indicate the foregut–midgut boundary
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foregut, they form a packet of post-mitotic but pre-migratory
neurons (Fig. 7, arrows) positioned adjacent to a rostral cluster
of glial precursor cells (arrowheads) that are associated with the
esophageal nerve (EN). By 40% of development, all of the EP
cells had begun to express ELAV; in contrast, msAPPL
expression was not detectable in these neurons until several
hours later, first appearing in the EP cells as they commenced
their slow circumferential spreading phase of migration around
the foregut (Fig. 7, 40–55% of development). Like ELAV,
msAPPL expression was restricted to the neurons of the ENS,
being absent from the enteric glia or underlying visceral
musculature. Throughout this period of development, msAPPLFig. 8. msAPPL continues to be expressed by the EP cells during their migration on
Identically staged embryos (58, 60, and 65% of development) were immunostained
(middle row), or ELAV (bottom row). Arrows indicate the leading processes of the E
the mid-dorsal set of muscle bands; compare with Fig. 4. In contrast, ELAV in Mand
boundary (fg/mg); scale bar = 30 Am.immunoreactivity was distributed in a punctate manner
throughout the cytoplasm of the EP cells, as well as within
their short filopodial processes extending on the adjacent
foregut and midgut surfaces (described below). Subsequently,
during their fast phase of migration onto the midgut muscle
bands (55–65% of development; Fig. 8), all of the EP cells
continued to express robust levels of APPL-related protein. As
with mFas II, msAPPL immunoreactivity could be clearly seen
in their leading processes and growing axons (Fig. 8, arrows),
in contrast to ELAV, which was largely confined to the
neuronal cell bodies.
The co-localization of msAPPL with mFas II was better
demonstrated in confocal images of preparations that hadto the midgut muscle bands and can be detected within their leading processes.
as whole-mount preparations with antibodies to fasciclin II (top row), APPL
P cells (at 58% and 60%) or their growing axons (at 65%) that extended along
uca is restricted to the neuronal somata. Black bars indicate the foregut–midgut
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proteins (Fig. 9). In actively migrating neurons (Fig. 9A;
58% of development), mFas II immunostaining (red) defined
the outline of the EP cells (arrows) and their leading
processes (arrowheads) and more faintly labeled their
underlying muscle band pathways (asterisks; as described
in Wright and Copenhaver, 2000). During this phase of
migration, robust APPL immunoreactivity (green) was
associated with the leading processes of the EP cells (Fig.
9A, arrowheads), as well as a more diffuse pattern of
punctate staining throughout their somata (arrows). At higher
magnification (Fig. 9B, different preparation than in panel
A), co-localization of msAPPL and mFas II could clearly be
seen within filopodia of leading processes of the EP cells
(arrowheads); intriguingly, msAPPL was distributed all the
way to the tips of some filopodia but not others, suggesting
that the trafficking of this protein is dynamically regulated
in these highly motile structures.Fig. 9. msAPPL undergoes developmentally regulated trafficking within the migrato
(red) and msAPPL (green). (A) In actively migrating EP cells (58% of development
cytoplasm of the EP cells and also co-localizes with mFas II in their leading process
mid-dorsal muscle band pathway. (B) Higher magnification view of the migrating EP
panel A) shows that msAPPL immunoreactivity is distributed to the tips of some f
partially out the length of others. Asterisks indicate the position of mid-dorsal p
Copenhaver, 2000). (C) In differentiated EP cells (95% of development), some msAP
cytoplasmic msAPPL immunoreactivity is confined to a perinuclear ring of vesicles
rows B and C.By 95% of development (Fig. 9C), a stage when the EP cells
have completed their differentiation (see Fig. 1), the distribu-
tions of both proteins had changed substantially. mFas II
immunoreactivity was primarily localized to the axons of the
EP cells that had grown around the cell bodies of neighboring
neurons, although some of this staining was associated with the
enteric glial cells that ensheath the EP cell bodies (Wright and
Copenhaver, 2000). APPL immunoreactivity was also still
expressed in the axons of the EP cells (Fig. 9C) and could be
faintly detected in their diffuse terminal branches on the
interband musculature (not shown). However, the cytoplasmic
component of msAPPL was now confined to a ring of large
perinuclear vesicles that did not contain mFas II (Fig. 9C,
arrows). These results indicate that, in addition to the
developmentally regulated processing of msAPPL shown in
Fig. 6, msAPPL (or its proteolytic fragments) undergoes
differential trafficking in the EP cells, coincident with the
different stages of neuronal migration and differentiation.ry EP cells. Confocal images of embryos double-immunostained for fasciclin II
), msAPPL immunoreactivity is distributed in a punctate manner throughout the
es (arrowheads); white arrows indicate positions of the leading EP cells on each
cells and their leading processes in a 58% embryo (different preparation than in
ilopodia associated with their leading processes (arrowheads) but only spreads
air of muscle bands, which also express faint levels of mFas II (Wright and
PL still co-localizes with the fasciculated axons of the EP cells, but most of the
within the neuronal somata (arrows). Scale bar = 30 Am in row A and 15 Am in
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migratory EP cells
Previously, we showed that the EP cells first express the
gene encoding the heterotrimeric G protein Goa just prior to
the onset of migration (Horgan et al., 1995) and that Goa is the
only G protein detectable in the leading processes of these
neurons during their subsequent migration and outgrowth
(Horgan et al., 1994, 1995). Since human APP695 has been
shown to interact directly with Goa in vertebrate cells
(Brouillet et al., 1999; Nishimoto et al., 1993), we used
confocal imaging of embryos that had been double-labeled
with antibodies against msAPPL and Goa to examine the
relative distributions of these two proteins in vivo. As shown in
Fig. 10A, the two proteins were spatially co-localized within
both the somata (arrows) and growing axons (arrowheads) of
the EP cells. Goa is also transiently expressed by the midline
cells (ml) lying between the muscle band pathways that areFig. 10. (A) Co-localization of msAPPL and the heterotrimeric G protein Goa in
antibodies against msAPPL (green) and Goa (red). Arrows indicate the leading ne
processes that have begun to elongate into incipient axons. (B) Co-localization of ms
indicate growing neurites containing both msAPPL and Goa immunoreactivity. (C)
between the mid-dorsal muscle bands that also express Goa but not msAPPL at 58%
panel C.followed by the migratory neurons (Horgan et al., 1994), but
these midline cells were devoid of msAPPL expression.
Because of relatively high background levels associated
with our anti-Goa antibody in whole-mount preparations, we
were unable to resolve the fine filopodial processes of the EP
cells in these preparations. As an alternative strategy, we
immunostained neurons grown in primary culture (3 days after
plating) for msAPPL and Goa. As shown in Figs. 10B–C, the
distribution of the two proteins largely overlapped within the
major neurites and finer filopodial extensions of cultured
neurons undergoing active outgrowth. These results indicate
that msAPPL and Goa are co-localized in the motile regions of
both central and peripheral neurons in Manduca.
To test whether msAPPL and Goa interact within the EP
cells, we immunoprecipitated msAPPL from extracts of
embryonic midgut and probed the immunoprecipitate with
the anti-Goa antibody. As shown in Fig. 11A, the initial midgut
extracts (‘‘input’’) contained a substantial amount of Goa.the migratory EP cells. Embryo at 60% of development immunostained with
urons on the two mid-dorsal muscle bands; arrowheads indicate their leading
APPL and Goa in a cultured primary neuron (3 days after plating). Arrowheads
Magnified views of the boxed regions indicated in panel B. ml = midline cells
of development. Scale bar = 15 Am in panel A, 5 Am in panel B, and 2 Am in
Fig. 11. Goa co-immunoprecipitates with msAPPL. (A) Immunoblot of
proteins derived from embryonic midgut and labeled with an anti-Goa
antiserum. Input = a control sample of the midgut lysate, showing that it
contains robust levels of Goa. Control IP = proteins that were immunopreci-
pitated with pre-immune sera (from the chicken used to generate our anti-
msAPPL-cyt antibody); no detectable Goa was seen in this sample, while the
residual supernatant from this immunoprecipitation reaction (‘‘control super-
natant’’) contained similar Goa levels as seen in the initial lysate (compare with
the ‘‘input’’ lane). In contrast, incubation of the midgut lysate with our anti-
msAPPL-cyt antibody co-immunoprecipitated Goa (‘‘anti-APPL IP’’); approx-
imately 10% of the total Goa in the initial lysate was co-precipitated by this
protocol. Residual levels of Goa (not co-precipitated by anti-msAPPL) are
shown in ‘‘anti-APPL supernatant.’’ No detectable Goa was seen when lysates
were incubated with an aliquot of the anti-msAPPL antibody that had been pre-
adsorbed against its peptide epitope (‘‘pre-adsorbed anti-APPL IP’’). (B) Co-
immunoprecipitation of Goa with msAPPL from lysates of desheathed pupal
ganglia (used to prepare our primary neuronal cultures; see Fig. 10). Lanes are
identical to those in panel A: lane 1 = input (ganglia lysate); lane 2 = control
immunoprecipitate (using pre-immune sera); lane 3 = residual supernatant from
the control immunoprecipitation shown in lane 2; lane 4 = immunoprecipitate
using anti-msAPPL antibodies, which contains about 10% of the total Goa seen
in the initial lysate (compare with lane 1); lane 5 = residual supernatant from
the immunoprecipitation reaction shown in lane 4. The size of Goa (41 kDa) is
indicated on the left of each panel.
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sera, no detectable Goa was seen in the precipitated protein
pellet (‘‘control IP’’). In contrast, when we immunoprecipitated
midgut extract with either of our anti-msAPPL antibodies,
approximately 10% of the total amount of Goa that was
detectable in the original lysate co-immunoprecipitated with
msAPPL (‘‘anti-APPL IP’’). Pre-incubation of the anti-
msAPPL antibodies with their peptide epitopes completely
abolished their ability to co-immunoprecipitate Goa (‘‘pre-
adsorbed anti-APPL IP’’). In a parallel study, we also co-
immunoprecipitated msAPPL and Goa from lysates of
desheathed CNS ganglia (isolated by the same protocol used
for preparing our primary neuronal cultures; see Fig. 10). As
with the embryonic midgut extracts, extracts of CNS ganglia
contained robust levels of Goa (Fig. 11B, lane 1). Pre-immune
serum failed to co-immunoprecipitate any detectable Goa (Fig.
11B, lane 2), whereas our anti-msAPPL antisera immunopre-
cipitated approximately 10% of the total Goa (Fig. 11B, lane 4)
detectable in the initial ganglia lysate. Neither of our anti-
msAPPL antibodies co-precipitated the related G protein Gsa
(not shown), providing further evidence that the interaction
between msAPPL and Goa is specific.These results show that msAPPL and Goa are closely
associated in Manduca neurons. Moreover, since the EP cells
are the only cells on the midgut that express detectable levels of
both msAPPL (Figs. 7–8) and Goa (Horgan et al., 1995), these
experiments indicate that msAPPL interacts with Goa specif-
ically in these migratory neurons. In combination with our
previous demonstration that Goa-mediated signaling inhibits
EP cell migration in vivo (Horgan and Copenhaver, 1998), our
data support a model whereby interactions between msAPPL
and Goa may regulate specific aspects of neuronal migration,
as discussed below.
Discussion
A potential role for APPL in the regulation of migration by
Goa
In previous work, we presented evidence that activation of
Goa in the EP cells negatively regulates their motile behavior:
Goa is expressed in the EP cells coincident with the onset of
their migration (Horgan et al., 1994) and activation of Goa
within individual EP cells leads to an inhibition of their
migration and outgrowth (Horgan and Copenhaver, 1998;
Horgan et al., 1994). This inhibitory effect of Goa was shown
to be mediated by Ca2+ influx via voltage-independent
channels; moreover, G protein activation induces the onset of
intrinsic Ca2+ spiking activity in the EP cells and results in a
down-regulation of their motility (Horgan and Copenhaver,
1998). Spontaneous Ca2+ spikes of similar amplitude can be
detected in the EP cells at the end of their migration, supporting
the conclusion that Goa-dependent activation of Ca2+ influx
normally regulates the guidance or extent of EP cell migration
and outgrowth along the midgut muscle bands (Horgan and
Copenhaver, 1998). Based on these results, we proposed a
model whereby Goa-coupled receptors expressed by the EP
cells would be activated by ligands encountered within the
local cellular environment, resulting in the stimulation of Goa-
mediated Ca2+ spiking activity in the EP cells and a
concomitant regulation of their migratory behavior (Horgan
and Copenhaver, 1998). However, the identity of candidate
receptors capable of activating Goa in these neurons remained
unknown.
The results described in current study suggest that msAPPL,
a member of the APP family of transmembrane proteins, may
serve this function. Our data show that msAPPL and Goa are
co-localized within the EP cells during their migration and
within the growing processes of neurons in primary culture
(Fig. 10). We have also shown that Goa can be co-
immunoprecipitated with anti-msAPPL antibodies from
extracts of both the ENS and CNS (Fig. 11). Given the high
degree of sequence similarity between the Goa binding domain
of human APP695 (Nishimoto et al., 1993) and the equivalent
domain in msAPPL (Fig. 2), these results are consistent with
the proposal that msAPPL and Goa directly interact in the EP
cells.
A hypothetical model supported by our data is that msAPPL
acts as an atypical Goa-coupled receptor in the EP cells that
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dependent manner (Fig. 12). In previous work, we showed that
the EP cells extend filopodial processes onto both the muscle
band pathways (B) and the adjacent interband regions (IB),
areas that are inhibitory to migration (Copenhaver et al., 1996).
Filopodia that extend onto the interband regions are signifi-
cantly shorter and have briefer lifespans than those that grow
along the muscle bands (unpublished observations), supporting
the notion that ligands (Fig. 12, red) encountered within the
interband regions may induce a local retraction response. By
the proposed model, binding of these ligands by msAPPL
would induce the local activation of Goa and Ca2+ influx in
filopodia growing onto the interbands, leading to their
retraction; msAPPL-dependent activation of Goa would
therefore serve to restrict the migration and outgrowth of the
EP cells to their permissive muscle band pathways. Alterna-
tively, more global activation of this signaling cascade within
an EP cell would inhibit its overall migration, a response that
might help regulate the normal distribution of these neurons to
the anterior segment of the midgut (Copenhaver and Taghert,Fig. 12. A model for the regulation of EP cell migration via msAPPL-
dependent activation of Goa. An EP cell that is migrating on a midgut muscle
band (B; blue) also extends multiple filopodia onto the adjacent interband
regions of the midgut (IB), which are inhibitory to migration. msAPPL (purple)
co-localizes with Goa in the leading processes of the migratory neurons, where
it is transiently oriented as a transmembrane receptor. An interaction between
specific ligands for msAPPL (red) on the interband cells would lead to local
activation of Goa within the EP cell, which in turn has been shown to trigger
the induction of Ca2+ spiking activity in migrating EP cells and an inhibition of
their motility (Horgan and Copenhaver, 1998). By this model, local activation
of Goa following msAPPL activation would induce the retraction of filopodia
from the interband regions, while global activation would result in a
termination of EP cell migration (and possibly lead to subsequent aspects of
neuronal differentiation; Copenhaver and Taghert, 1989b). This model can now
be tested by interfering with msAPPL expression in the EP cells (which should
induce ectopic migration) and by examining whether activation of msAPPL
leads to the induction of Goa-sensitive Ca2+ spiking activity.1989a,b). As with APP695, authentic ligands for msAPPL
remain unknown, but they might include either membrane-
associated molecules or secreted factors derived from interband
cells, both of which would be readily accessible to msAPPL in
the leading processes of the EP cells.
Support for this model may be inferred from a variety of
studies in other systems. APP-related proteins are expressed in
high levels within in the leading processes and growth cones of
motile neurons in all species examined (Moya et al., 1994;
Lahiri et al., 2002; Clarris et al., 1995; Ohta et al., 1993), and
experiments in cell culture have shown that APP (or its
proteolytic derivatives) can modulate neuronal motility and
outgrowth in a variety of contexts (Kibbey et al., 1993; Beher
et al., 1996; Perez et al., 1997; Qiu et al., 1995). Although an
authentic role for human APP695 in the developing nervous
system remains controversial, a recent study on triple-knockout
mice lacking APP and the related genes APLP1 and APLP2
revealed a dramatic defect in neuronal migratory behavior:
subsets of cortical neurons in these mice failed to recognize
their normal cues to terminate migration, resulting in aberrant
migration through the overlying pial layer (Herms et al., 2004).
Similarly, a recent examination of developing neuromuscular
junctions in mice lacking both APP and APLP2 revealed that
these animals exhibit defective synaptic structures associated
with excessive nerve terminal sprouting (Wang et al., 2005). In
preliminary studies, we recently found that inhibition of
msAPPL expression (using msAPPL-specific morpholino
probes) resulted in excessive, inappropriate migration by the
EP cells onto the normally inhibitory interband regions of the
midgut, consistent with the model shown in Fig. 12 (Copen-
haver et al., unpublished data). Although in both mice and
Manduca, the cues that are recognized by APP-related
molecules remain to be determined, these results support the
hypothesis that members of the APP family may act as
transmembrane receptors involved in the regulation of neuronal
migratory behavior and outgrowth.
Precedent for our model that msAPPL may act as a novel
Goa-coupled receptor can also be found in studies on human
APP695. Nishimoto et al. showed that Goa (but not other G
proteins) binds directly to a cytoplasmic domain of APP695
containing a TPEERH motif (Nishimoto et al., 1993), an amino
acid sequence that is 100% conserved in Manduca msAPPL
(Fig. 2). Moreover, activation of APP695 with an antibody
against its ectodomain induced a significant increase in GTPgS
turnover by Goa, analogous to G protein activation by
conventional G-protein-coupled receptors (Nishimoto et al.,
1993; Okamoto et al., 1995). This same group showed that one
class of APP695 mutations linked to Familial AD caused these
proteins to act as constitutively active Goa-linked receptors
when incorporated into vesicles (Okamoto et al., 1996) or in
cultured cells (Ikezu et al., 1996). The direct interaction
between APP695 and Goa was verified in other experiments
using neuronal membranes (Brouillet et al., 1999), although, in
this study, activation of APP695 caused an inhibition of Goa
GTPase activity, underscoring the challenges of working with
isolated membrane preparations. Nevertheless, these studies
advanced the provocative model that APP may act as a novel
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although the downstream signaling events that may be
modulated by APP proteins remain undefined (Turner et al.,
2003). Our demonstration that msAPPL interacts with Goa in
the EP cells provides a model system that can now be used to
test the role of this APP family protein in regulating neuronal
motility, specifically via the modulation of Ca2+ spiking
activity in vivo; these experiments are currently underway.
Relationship of msAPPL to other APP family proteins
As noted above, msAPPL shares most of the major
structural features found in other APP family proteins,
including conserved motifs in both the extracellular and
intracellular domains that have been implicated in a variety
of potential interactions with other proteins (Fig. 2; Supple-
mental Fig. 2; De Strooper and Annaert, 2000; Turner et al.,
2003). Like ‘‘neuronal’’ APP695 and fly dAPPL (Rosen et al.,
1989), msAPPL lacks the KPI domain found in the larger APP
isoforms that are expressed in non-neuronal cells (Turner et al.,
2003). Both Manduca and Drosophila APLPs are expressed
exclusively in neurons (Figs. 4–6; Martin-Morris and White,
1990), although they lack obvious homology with the Ah
region of human APP695. In this regard, the insect versions of
this protein more closely resemble the vertebrate APLPs, which
have been postulated to have arisen along with APP via gene
duplication from a single ancestral gene (Coulson et al., 2000).
Our data also indicate that, like human APP695 (Walter et al.,
2001) and fly dAPPL (Luo et al., 1990), msAPPL is expressed
as a glycosylated transmembrane protein that is rapidly
processed to produce a smaller secreted ectodomain fragment.
In the CNS, the holoprotein appears primarily as a 135 kDa
protein that can be processed by secretase-like activity to
produce a soluble 120 kDa fragment. As shown in Fig. 3, we
were able to detect this 120 kDa fragment but not the 135 kDa
protein in the medium of cultured primary neurons, using our
antibody against the N-terminal domain of msAPPL but not
with our C-terminal-specific antibody. These data support our
conclusion that the 120 kDa protein represents the cleaved
ectodomain fragment of the holoprotein. Notably, we only
detected the 120 kDa protein in the medium surrounding the
neurons after several days in culture, suggesting that continued
expression and cleavage of msAPPL lead to the gradual
accumulation of this fragment as the neurons grow. Other
bands recognized by our C-terminal-specific antibody (includ-
ing the 135 kDa isoform) were not detected in the medium, nor
was the 120 kDa band seen in control samples of the culture
medium (not shown). We also obtained analogous results when
we expressed msAPPL in Drosophila S2 cells, similar to
previous published studies by Luo et al. on dAPPL (Luo et al.,
1990), albeit with somewhat altered apparent molecular
weights (unpublished data). These results support the conclu-
sion that msAPPL undergoes secretase-dependent processing
in a manner similar to that of other APP family members.
Although the specific identity of the secretases responsible for
msAPPL processing in Manduca have yet to be verified, we
have now isolated cDNAs encoding evolutionarily conservedmembers of all of the a-, h-, and g-secretase families
implicated in APP695 processing (De Strooper and Annaert,
2000). In future work, we intend to investigate how secretase-
dependent cleavage of msAPPL affects different aspects of EP
cell motility in vivo.
Dynamic features of msAPPL expression during migration
Several aspects of msAPPL expression in the EP cells may
pertain to its potential role as a guidance receptor involved in
modulating neuronal migration. First, expression of msAPPL-
specific mRNA (Fig. 4) and protein (Fig. 7) was initially
detected in the EP cells just prior to the onset of their slow
spreading phase of development, several hours after the
completion of their terminal mitoses (Copenhaver and
Taghert, 1990) and after the onset of ELAV expression (Fig.
7). These results are consistent with the delayed expression of
dAPPL in the Drosophila CNS, which is detectable only after
the expression of other neuronal-specific markers (Martin-
Morris and White, 1990). Because the EP cells are the only
neurons on the midgut during embryogenesis, immunoblots of
this tissue provided an accurate view of msAPPL processing
in the EP cells at different stages of their development (Fig.
6B). Notably, during periods of active migration and
outgrowth, much of the msAPPL associated with the EP
cells appeared to undergo extensive post-translational modi-
fication, resulting in the three prominent bands at 155–180
kDa. By the completion of embryogenesis, these larger
isoforms were no longer apparent, so that virtually all of
the full-length proteins migrated at 135 kDa (as seen in
extracts of the CNS). These results suggest that stage-specific
regulation of post-translational processing events may con-
tribute to the developmental role of msAPPL in actively
motile neurons.
The nature of the modifications that contribute to the
apparent size of these larger isoforms remains incompletely
understood. As shown in Fig. 6C, PNGase F treatment of
lysates prepared with hot extraction buffer suggested that the
trio of bands at 155–180 kDa may be hyperglycosylated forms
of full-length APPL; however, this protocol failed to shift the
apparent size of the 135 and 120 kDa proteins, which is
inconsistent with published reports that both the holoprotein
and secreted ectodomains of APP proteins are glycosylated
(Luo et al., 1990; Oltersdorf et al., 1990). In contrast, PNGase
treatment of lysates prepared in RIPA buffer did shift these
bands by 3–4 kDa but only reduced the larger trio of bands by
10–15 kDa. Our hot extraction protocol might possibly
sensitize carbohydrate side chains on msAPPL that are
normally resistant to PNGase treatment, although treatments
with O-glycanase and Fucosidase had no effect on any of the
msAPPL-associated bands. APP family proteins are also
subject to phosphorylation (Russo et al., 2005) and sumoyla-
tion (Li et al., 2003), but such modifications should not be
affected by the protocols used in this study. Alternatively, the
higher molecular weight bands might be due in part to
homodimerization of msAPPL isoforms, as has been suggested
for human APP695 (Scheuermann et al., 2001). In such a case,
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might have serendipitously disrupted potential homophilic
interactions, resulting in the shift in apparent molecular weights
that we observed.
Although the significance of these different aspects of
msAPPL processing remain to be explored in terms of the
control of neuronal migration, these results suggest that the
post-translational modification and rapid turnover of trans-
membrane msAPPL may play important roles in regulating
the distribution and bioavailability of the holomolecule or its
proteolytic fragments. For example, studies performed with
rat neuronal membranes showed that only a small fraction of
intact APP was accessible to the extracellular space at any
given time, but that this same fraction co-localized with Goa
and was responsible for modulating GTPgS turnover when
activated by antibody cross-linking (Brouillet et al., 1999).
Consistent with this view, immunostaining unpermeabilized
preparations of the ENS with our anti-msAPPL antibodies
resulted in a greatly diminished signal compared to that seen
in fixed permeabilized embryos (unpublished observations),
indicating that the holoprotein of msAPPL may reside on the
surface of growing neurons only briefly before being
proteolytically cleaved. This pattern of rapid expression and
processing of a potential guidance receptor might provide a
means of continually refreshing a neuron’s response to
dynamic changes in the extracellular cues that it encounters
during its migration into the ENS. In this regard, the
distribution of msAPPL on the leading processes of the
migrating EP cells is intriguing, in that we observed that
msAPPL extended into the distal tips of some filopodia but
not others (Fig. 9). In the context of our proposed model,
msAPPL may preferentially traffic to filopodia that are
undergoing active elongation and are therefore most likely
to encounter potential ligands in the local environment;
alternatively, the protein might accumulate in filopodia that
have become stabilized and are forming focal contacts, as has
been suggested from studies of mouse APP in transfected
cells and primary neuronal cultures (Sabo et al., 2001, 2003).
Lastly, while msAPPL expression remained strong in the EP
cells throughout their differentiation, we noted a marked
redistribution of the protein as the neurons matured. During
their active phase of migration, msAPPL was distributed in a
punctate manner throughout the EP cells, consistent with the
vesicular trafficking of APP by fast anterograde transport
(Lazarov et al., 2005; Stokin et al., 2005). In addition, a
fraction of msAPPL also co-localized with mFas II (Fig. 9) and
Goa (Fig. 10) in the leading processes and axons of the EP
cells in vivo and CNS neurons grown in primary culture,
lending credence to our model that msAPPL-dependent
activation of Goa plays a role in migratory guidance. By the
end of embryogenesis, however, most msAPPL within the
somata of the EP cells was confined to a ring of large
perinuclear vesicles (Fig. 9C), although some of the proteins
remained associated with the axonal fascicles and terminal
branches of these neurons. While the identity of these
perinuclear vesicles is still unknown, they resemble the
intracellular compartments in which vertebrate APPs (or theirderivatives) have been shown to accumulate (Lee et al., 2003;
Nixon et al., 2000; Takahashi et al., 2004), which may be
endosomal or lysosomal in nature.
These results suggest that msAPPL may be differentially
trafficked during EP cell development so that membrane-
associated msAPPL is concentrated in regions of active
motility and target innervation, while much of the remaining
protein or its processed fragments become localized within this
perinuclear compartment. Although cytoplasmic fragments of
human APP695 have been shown to be capable of trafficking to
the nucleus and regulating gene transcription (Kinoshita et al.,
2002; but see Cao and Sudhof, 2004), the pattern of
sequestration that we observed at the completion of migration
and outgrowth would also provide an effective means of
limiting the capacity of msAPPL to modulate Goa activity. In
summary, our data indicate that in actively migrating EP cells,
msAPPL undergoes a dynamic sequence of post-translational
modification, trafficking, and processing, consistent with the
view that this protein may play an important role in regulating
one or more aspects of directed neuronal migration in this
system.
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